For tracking purposes, the Department, upon recommendation of the PMPAC, may designate and list drugs, other substances, and immediate precursors as:
a) A Schedule I if the Department finds that:1)the substance has high potential for abuse; and2)the substance has no currently accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision [720 ILCS 570/203] .b) A Schedule II if the Department finds that:1)the substance has high potential for abuse;2)the substance has currently accepted medical use in treatment in the United States, or currently accepted medical use with severe restrictions; and3)the abuse of the substance may lead to severe psychological or physiological dependence [720 ILCS 570/205 ].c) A Schedule III if the Department finds that:1)the substance has a potential for abuse less than the substances listed in Schedules I and II;2)the substance has currently accepted medical use in treatment in the United States; and3)abuse of the substance may lead to moderate or low physiological dependence or high psychological dependence [720 ILCS 570/207] .d) A Schedule IV if the Department finds that:1)the substance has a low potential for abuse relative to substances in Schedule III;2)the substance has currently accepted medical use in treatment in the United States; and3)abuse of the substance may lead to limited physiological dependence or psychological dependence relative to the substances in Schedule III [720 ILCS 570/209] .e) A Schedule V if the Department finds that: 1)the substance has low potential for abuse relative to the controlled substances listed in Schedule IV;2)the substance has currently accepted medical use in treatment in the United States; and3)abuse of the substance may lead to limited physiological dependence or psychological dependence relative to the substances in Schedule IV, or the substance is a targeted methamphetamine precursor as defined in the Methamphetamine Precursor Control Act [720 ILCS 648 ]. [720 ILCS 570/211] f) Other Selected Drugs, including: 1) those medications that may contribute to clinical reviews of scheduled medications;2) those medications determined to need additional monitoring or to assist in facilitating medication optimization and utilization; and3) the dispensing of Naloxone for opioid overdose prevention.Ill. Admin. Code tit. 77, § 2080.230
Added at 39 Ill. Reg. 6421, effective 4/22/2015Amended at 41 Ill. Reg. 11909, effective 9/13/2017Amended at 47 Ill. Reg. 13500, effective 9/8/2023